---
schema_version: "secwatch.filing_event.v1"
accession: "0001404644-24-000041"
form_type: "8-K"
ticker: "NGNE"
cik: "0001404644"
company_name: "Neurogene Inc."
filed_at: "2024-04-25T23:59:59+00:00"
generated_at: "2026-06-03T07:43:30.140408+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Neurogene amends CSO Stuart Cobb's consulting agreement; sets $440K annual fee, success bonus up to 40%

## Summary
- Dr. Stuart Cobb to continue as CSO under amended consulting agreement with Neurogene.
- Minimum annual consulting fee of $440,000 paid monthly; eligible for annual success fee of up to 40%.
- Termination without cause or for good reason: lump sum of 1.0x annual fee plus pro-rata bonus (non-CIC) or (CIC) includes equity acceleration.
- Agreement effective April 19, 2024; replaces prior consulting agreement from December 2018.

## SEC filing metadata
- accession: 0001404644-24-000041
- form_type: 8-K
- ticker: NGNE
- cik: 0001404644
- company_name: Neurogene Inc.
- filed_at: 2024-04-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404644/000140464424000041/0001404644-24-000041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404644/000140464424000041/ngne-20240419.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001404644-24-000041
- JSON: https://secwatch.observer/filing/0001404644-24-000041.json
- Plain text: https://secwatch.observer/filing/0001404644-24-000041.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.